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Abstract 
 
ARE CAFFEINE’S EFFECTS ON NEURONAL CALCIUM LEVELS DUE TO THE 
CAFFEINE METABOLITE, PARAXANTHINE? 
 
Kendra Jean Hartsuyker 
 
 Caffeine has diverse effects on neurons including, potentially, protection against 
Parkinson’s-related neurodegeneration. Caffeine may protect neurons from damage by 
limiting mitochondrial membrane permeability through a calcium-dependent mechanism. 
This study was a first step investigating calcium’s role in caffeine neuroprotection in vivo 
using zebrafish larvae.  Elavl3:GCaMP6s zebrafish, which express a genetically encoded 
fluorescent calcium indicator protein in most CNS neurons, received caffeine (0, 50, 125, 
250 µM, bath applied) in an ascending dose series during fluorescence calcium imaging 
of a central catecholaminergic nucleus (a proposed zebrafish homolog of the locus 
coeruleus, a structure affected in Parkinson’s disease). Parallel experiments tested effects 
of an ascending dose series of paraxanthine (0, 40, 100, 200 µM), a neuroactive caffeine 
metabolite, to assess whether paraxanthine mediates caffeine effects. Five outcomes were 
measured: spontaneous calcium oscillations, visually-evoked calcium responses, 
spontaneous swimming activity, visually-evoked swimming, and heart rate (visual 
responses were evoked by a sudden dimming of ambient illumination). Caffeine and 
paraxanthine had no effect on the power of low frequency (<2Hz) calcium oscillations, 
visually-evoked calcium responses, or heart rate, even at the highest doses. High doses of 
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caffeine and paraxanthine moderately but significantly suppressed swimming speed 
during visually-evoked behavioral responses. Results suggest that the dose range used 
was too low to produce expected effects of caffeine. Alternatively, caffeine may affect 
stressed neurons differently from healthy neurons, a possibility we will examine in 
similar experiments using MPTP challenge. 
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Introduction 
Parkinson’s disease (PD) is characterized as a neurodegenerative disorder 
affecting mostly the elderly population. The neurodegeneration targets dopamine (DA) 
producing neurons in the pars compacta of the substantia nigra (SN). The decrease in 
dopaminergic neurons and subsequent DA loss has been hypothesized as a leading cause 
to the debilitating degradation of voluntary motor control commonly seen in PD patients. 
In PD, the root cause of DA cell death is still unknown (Lang & Lozano, 1998). One 
theory examining mutations in mitochondrial DNA (mtDNA) proposes the propagation 
of dopaminergic cell death may be due in part to a mitochondrial complex I deficiency in 
PD patients. The mitochondrial complexes are proteins composing the electron transport 
chain involved in energy production. Impairment of mitochondrial complex I may lead to 
a significant increase in a toxic metabolite of DA, called 3, 4-dihydroxy-
phenylacetaldehyde (DOPAL), because of a decrease in nicotinamide adenine 
dinucleotide (NAD), a cofactor for the enzyme responsible for metabolizing DOPAL.  
(Burke et al., 2004; Lang & Lozano, 1998; Panneton, Kumar, Gan, Burke, & Galvin, 
2010; Schapira et al., 1990). With this deficit, DOPAL accumulates in higher 
concentrations than the average population. DOPAL reacts with H2O2 to produce free 
radicals (Li, Lin, Minteer, & Burke, 2001). The concentrations of free radicals are 
proposed to occur in high enough concentrations to induce the permeability transition 
pore (PTP) of the mitochondria to change to its full conductance state (Burke et al., 2004; 
Kluck, Bossy-Wetzel, Green & Newmeyer, 1997; Li et al., 2001; Scarlett & Murphy, 
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1997). The PTP is a structure spanning the inner membrane and outer membrane 
of the mitochondria allowing flow of calcium ions between the matrix and the cytoplasm. 
Changing the PTP into its full conductance state disrupts the electrochemical gradient 
causing swelling of the matrix releasing cytochrome c, a small protein, into the matrix 
resulting in apoptotic cell death (Kristal, Matsuda, & Byung, 1996; Li et al., 2001). 
 Paraxanthine, the primary metabolite of caffeine, has neuroprotective effects on 
DA cells in models of PD (Guerreiro, Toulorge, Hirsch, Marein, Sokoloff, & Michel, 
2008; Xu, Xu, Chen, Schwarzchild, 2010). It is established that the neuroprotective effect 
of paraxanthine is dependent on activation of ryanodine receptors (Guerreiro et al., 2008). 
Ryanodine receptors are calcium (Ca2+) release channels located on the outer face of the 
endoplasmic reticulum (ER) (Fill & Copello, 2002; Verkhratsky, 2005). Mitochondria are 
physiologically close enough to the ER to create Ca2+ “hotspots”. These microdomains of 
Ca2+ inhibit the mitochondria PTP from opening in its high conductance state, thus 
preventing apoptotic cell death (Burke et al., 2004; Li et al., 2001; Mannella, Buttle, 
Rath, & Marko, 1998; Rizzuto et al., 2003; Rizzuto, DeStefani, Raffello, & Mammucari, 
2012; Szalai, Krishnamurth, & Hajnóczky, 1999; Szalai, Csordas, Hantash, Thomas, & 
Hajnóczky, 2000; Verkhratsky, 2005). 
 Zebrafish are a widely used model organism in drug discovery. Functional 
domains within proteins are highly conserved allowing the zebrafish to have a high 
degree of drug response and physiological similarity to humans. The proposed 
experiments will take advantage of the ability to measure neuronal calcium dynamics in 
intact zebrafish larvae using optical methods to investigate how caffeine and 
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paraxanthine affects intracellular calcium. By establishing the concentrations of both 
compounds that are effective in activating the release of Ca2+ from the ER, these 
experiments will provide critical information for subsequent studies designed to test 
whether Ca2+ release from the ER protects against PD-related neuronal degeneration.  
Paraxanthine is an active metabolite of caffeine and has not been tested in the zebrafish 
before, so a secondary goal of these experiments is to determine to what extent caffeine’s 
effects on neuronal calcium levels depends on the actions of paraxanthine.  
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Literature Review 
Parkinson’s Disease 
Parkinson's’ disease (PD) has been classified as a neurodegenerative movement 
disorder commonly diagnosed in the elderly population. PD affects approximately 2% of 
the population over the age of 65 and 4-5% of the population over the age of 85, although 
these are likely under estimates as under-diagnosis is fairly common (Lang & Lozano; 
1998; Eriksen, Dawson, Dickson, & Petrucelli, 2003). Classic PD symptoms have been 
characterized as bradykinesia, akinesia, rigidity, resting tremors, depression, sleep 
deficits, and an impaired gait. (Lang & Lozano; 1998). The major symptoms of PD have 
been linked to a loss of dopaminergic neurons in the Substantia Nigra (SN) and a loss of 
dopamine (DA) in the Striatum (Burke et al., 2004; Hornykiewicz, 1993; Fearnley & 
Lees, 1991; Panneton et al., 2010). The nigrostriatal DA neurons are responsible for 
control over voluntary movements (Grillner & Mercuri, 2002). 
Current treatments for PD, including the dopamine precursor drug, L-DOPA, and 
deep brain stimulation, are focused on increasing DA availability in the synapse or 
reducing tremors (Benabid, Chabardes, Mitrofanis, & Pollak, 2009; Cesura & Pletscher, 
1992; Cools, Barker, Sahakain, & Robbins, 2003; Stefani et al., 2007). These treatments 
relieve symptoms but do not prevent the continued death of dopaminergic neurons. 
Therefore, genetic and cellular mechanisms of PD neurodegeneration are under active 
investigation to identify degenerative processes that may be disrupted to rescue stressed 
neurons and prevent further cell loss (Luo, Hoffer, Hoffer, & Oi, 2015; McNeill et al., 
2013; Winklhofer & Haas, 2011). Some of this research has revealed intracellular 
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calcium regulation to be a critical process in dopaminergic cell loss and one that could 
potentially be manipulated therapeutically (Cali, Ottolini & Brini, 2014; Hurley & 
Dexter, 2012; Mattson, 2012; Orrenius, Nicotera, & Zhivotovsky, 2003; Rizzuto et al., 
2003).   
Genetic mutations affecting mitochondria in Parkinson’s Disease. Many 
studies have tried to find genes linked to PD predisposition (Klein & Westenberger, 
2012; Polymeropoulos et al., 1997). However, these studies are examining nuclear genes 
and have failed to find correlations, only found small effect sizes, or only accounted for a 
small percent of PD cases. (Klein & Westenberger, 2012; Polymeropoulos et al., 1997). 
Examining mitochondrial (mtDNA) may provide insight behind the pathology of PD. 
mtDNA base pair deletions or insertions have already been identified in the pathology of 
neurodegenerative diseases such a PD and Alzheimer’s disease (Wallace, 1999). 
Inheritance of mitochondria during cell proliferation varies due to random chance. 
Understanding the cellular inheritance pattern within an organism is important for 
understand the role of mtDNA in disease because it explains the phenotypic variance that 
occurs within cell populations. 
Phenotypic expression of symptoms originating from mtDNA mutations are 
highly variable (Wallace, 1999). If two individuals, even from the same family, have the 
same mutation in their mtDNA, their phenotypic expression of the mutation may be 
drastically different. Each cell holds a combination of hundreds mutant and wild type 
mitochondria and within each mitochondria anywhere between 1,000 and 10,000 copies 
of mtDNA are contained (Wallace, 1992; Winklhofer & Haass, 2011). Figure 1 shows the 
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mitochondria in a cell undergoing mitosis. The mutant and wild type mitochondria are 
randomly divided between the daughter cells. After multiple cellular divisions, genetic 
variability among the ratio of mutant mitochondria and wild type mitochondria within the 
cell may develop, and the mutant phenotype may be expressed in cells harboring a 
greater ratio of the mutant mitochondria. The complex genetic and phenotypic variability 
among cells with mtDNA mutations within individuals may be a contributing reason the 
link of mutations in mtDNA and PD has been hard to establish.  
Another impairment of normal mitochondrial function associated with PD 
involves a mutation in mitochondrial complex I, which is the first protein in the electron 
transport chain, leading to a deficit within PD patients.  A deficiency in complex I 
downregulates the production of nicotinamide adenine dinucleotide (NAD), which is a 
cofactor needed for the enzyme aldehyde dehydrogenase (ALDH) to break down DOPAL 
into 3,4-dihydroxyphenylacetic acid (DOPAC) (Burke et al., 2004). A study showed that 
inhibiting ALDH increases DOPAL concentrations 12-fold when compared to controls 
(Lamensdorf et al., 2000).  
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 Figure 1. Illustrates how uneven distribution of mutated mtDNA within cells undergoing 
mitosis can lead to a variety of different phenotypes 
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Mitochondrial function, dopamine metabolism, and risks for cell death 
To understand the impact of a deficiency in complex I of the mitochondria, we 
must examine the metabolic pathway of DA. Tyrosine is metabolized by tyrosine 
hydroxylase into L-DOPA. DA is then synthesized from L-DOPA by DOPA 
decarboxylase in the SN (Burke et al., 2004). Figure 2 shows DA is then metabolized 
into 3, 4-dihydroxyphenylacetaldehyde (DOPAL) by monoamine oxidase (MAO) 
(Cesura & Pletscher, 1992). It is important to note hydrogen peroxide (H2O2) is also 
formed in the same reaction during the metabolism of DA into DOPAL (Burke et al., 
2004).  
In humans, there are two distinct isoforms of MAO: MAO-A, located on the 
cytosolic face of the mitochondria in the neurons, and MAO-B, located in the 
surrounding astrocytes (Burke et al., 2004). MAO-A is the only MAO isoform 
responsible for DA metabolism in striatal DA neurons (Fornai et al., 2000).  
 Although naturally forming, DOPAL is an unstable molecule, this instability can 
make DOPAL toxic under certain cellular conditions, such as in the presence of H2O2 
(Burke et al., 2004; Panneton et al., 2010). Normally DOPAL is rapidly cleaved by 
aldehyde dehydrogenase (ALDH) into a less volatile molecule, DOPAC (Cesura & 
Pletscher, 1992; Fornai et al., 2000; Panneton et al., 2010).  
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Figure 4. Shows the location of the metabolic pathway of dopamine.  The boxes 
represent compounds and the circles represent enzymes. MAO-A, located on the 
cytosolic face of the mitochondrion, metabolizes dopamine into DOPAL. The temporal 
location of DOPAL and H2 
 
Figure 5. a. The structure of the mitochondrion illustrating the low pH of the 
intramembrane space and the high pH of the matrix. b. Represents the mitochondrial 
permeability transition pore. The low conductance state shows a low flow of calcium 
ions exiting the matrix to the cytoplasm. The high conductance state illustrates a high 
flow of calcium ions exiting the matrix, along with the release of the protein 
CypDFigure 6. Shows the location of the metabolic pathway of dopamine.  The boxes 
represent compounds and the circles represent enzymes. MAO-A, located on the 
cytosolic face of the mitochondrion, metabolizes dopamine into DOPAL. The temporal 
location of DOPAL and H2 
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Evidence of DOPAL’s Toxicity 
The most common PD medication, L-DOPA, is a metabolic precursor to DA. By 
increasing the precursor compound, L-DOPA treatment increases DOPAL concentrations 
downstream in the dopaminergic pathway. PD patients already experience higher than 
average DOPAL levels due to a deficiency in mitochondrial complex I. Here we examine 
how L-DOPA treatment, already causing an increase in DOPAL, may be interacting with 
a mitochondrial complex I deficiency, a separate mechanism increasing DOPAL, to 
further propagate dopaminergic cell death. 
Evidence shows DOPAL, the primary metabolite of DA, can be toxic under 
certain circumstances to the cells it is formed in, particularly for dopaminergic cells 
within the SN (Panneton et al., 2010). The pars compacta of the SN, which is the group 
of neurons controlling reward and movement, was particularly more affected by DOPAL, 
due to the high concentrations of dopaminergic neurons, than the pars reticulata of the 
SN, which has a relatively high concentration of GABAergic neurons (Panneton et al., 
2010). This is suggestive DOPAL is selectively toxic to DA neurons. An analysis of 
postmortem human brain tissue from healthy donors showed an average DOPAL 
concentration of 2.3 µM within the SN (Kristal, Conway, Brown, Jain, Ulluci, Li, & 
Burke, 2001). This concentration was not found to be toxic to the cells. However, an in 
vivo study showed that a slightly higher DOPAL concentration, 6 µM, is toxic to neurons 
(Kristal et al., 2001). Injections of DOPAL into rat brains resulted in the loss of DA 
neurons with concentrations of DOPAL as low as 100 ng (Burke et al., 2004). However, 
injections at concentrations of 500 ng of DA showed no effects on DA neurons (W. 
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Burke et al., 2004). Although DA is closely related to DOPAL, DA itself is not toxic 
unless present in large concentrations, approximately 1M (Burke, Li, Williams, & Zham, 
2003; Burke et al., 2004; Filloux & Townsend, 1993; Kristal et al., 2001).  
L-DOPA, the most common PD medication, significantly increases DOPAL 
concentrations. Injections of 10 µM of DA through dialysis probes into rat brains 
increased DOPAL by 2,790% ±62 when compared with baselines (Fornai et al., 2000). 
Similarly, injections of 50 mg/kg of L-DOPA through dialysis probes into rat brains 
increased DOPAL levels by 1,861% ±70when compared to controls (Fornai et al., 2000). 
In both experiments, DOPAC, the metabolite of DOPAL, did not experience a significant 
increase. This is indicative of a “build up” of DOPAL within the brain. L-DOPA 
treatments may lead to concentrations of DOPAL reaching toxic levels within cells.  
In PD patients, the aforementioned mitochondrial complex I deficiency combine 
with L-DOPA treatment may cause a significant increase in the cellular concentration of 
the toxic compound DOPAL, furthering the propagation of DA cell death. The 
mechanism of DOPAL mediated toxicity has been attributed to the production of free 
radicals in the presence of H2O2 (Burke et al., 2004; Li et al., 2001). As mentioned above, 
H2O2 is produced in the same reaction DOPAL is metabolized from DA (Burke et al., 
2004). The authors note the mechanism the free radicals are formed is unknown and a 
recent literary search shows it is still unknown (Li et al. 2001). Free radicals are able to 
induce the mitochondrial PTP into its full conductance state causing mitochondrial 
swelling and the release of apoptotic proteins (Kristal et al., 1996; Li et al., 2001). This 
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points to a therapeutic target by preventing free radicals from inducing the mitochondrial 
PTP into its full conductance state. 
The mitochondria’s major role within the cell is regulation of energy metabolism 
and regulation of apoptotic pathways. Figure 3a shows the structure of mitochondria. It is 
important to understand mitochondria structure for energy production and regulation of 
apoptosis. Figure 2a shows mitochondria have two membranes, the outer membrane that 
segregates the mitochondria from the intracellular environment (cytoplasm) and the inner 
membrane that segregates the center of the mitochondria (matrix) from the 
intermembrane space. These properties allow the generation of proton gradient across 
membranes within mitochondria, and the dissipation of those proton gradient to drive the 
production of adenosine triphosphate (ATP). 
The mitochondrial PTP plays a critical role in normal mitochondrial function by 
regulating the conductance of calcium between the matrix and the cytoplasm 
(Azarashvili, Stricker, & Reiser, 2010; Ichas & Mazat, 1998; Patergnani et al., 2011; 
Rizzuto et al., 2012; Szalai et al., 2000). Changes in the PTP activity can also contribute 
to apoptosis (Azarashvili et al., 2010; Ichas & Mazat, 1998; Klucket al., 1997; Szalai, 
Krishnamurthy, & Hajnoczky 1999). 
Figure 3b shows the mitochondrial PTP is comprised of three proteins spanning 
the outer membrane of the mitochondria to the matrix (Arrazola, Silva-Alvarez, & 
Inestrosa, 2015; Azarashvili et al., 2010). One protein, the voltage dependent anion 
channel (VDAC) is located on the outer membrane. A second component, adenine 
nucleotide translocase (ANT) spans the inner membrane. The third component, 
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cyclophilin D (CypD) is located on the matrix side of the inner membrane and is released 
during PTP mediated cell death (Arrazola et al., 2015; Azarashvili et al., 2010). 
The mitochondrial PTP operates in two distinct pathways, one controls Ca2+ 
signaling and the other controls the effector phase of apoptosis (Ichas & Mazat, 1998). 
The PTP controls these pathways by openning in two different conductance states (Ichas 
& Mazat, 1998). Figure 3b shows the conformation changes the VDAC, ANT, and CypD 
proteins undergo to alter the conductance states and change the flow of Ca2+ ions 
(Arrazola et al., 2015). The low conductance state is a regular part of maintaining cellular 
Ca2+ homeostasis and normal cell functioning (Ichas & Mazat, 1998).  
The high conductance state stabilizes the channel in a permanent open 
conformation resulting in apoptosis (Ichas & Mazat, 1998). This causes an irreversible 
dissipation of the membrane potential resulting in the loss of mitochondrial structure 
through swelling of the mitochondrial matrix (Ichas & Mazat, 1998). The swelling forces 
the outer mitochondrial membrane to burst resulting in the release of the apoptotic 
proteins into the cytoplasm (Burke et al., 2004; Ichas & Mazat, 1998; Kothakota et al., 
1997; Kluck et al., 1997; Orrenius et al., 2003; Scarlett & Murphy, 1997; Youle & 
Strasser, 2008).  
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Figure 7. a. The structure of the mitochondrion illustrating the low pH of the 
intramembrane space and the high pH of the matrix. b. Represents the mitochondrial 
permeability transition pore. The low conductance state shows a low flow of calcium ions 
exiting the matrix to the cytoplasm. The high conductance state illustrates a high flow of 
calcium ions exiting the matrix, along with the release of the protein CypD 
 
Figure 8. Quantification of spontaneous calcium fluorescence. A. Raw confocal video stack 
consisting of 6,000 frames. B. Projection of average pixel values across the stack. Arrow 
heads show individual neuron cell bodies the tart nucleus that can be resolved. C. 
Threholded image showing isolation of the target nucleus as a density (particle) of blue 
pixels. A smaller particle in the upper right of the image is not included because of a size 
cut off. D. Isolated region of interest for subsequently measuring each from in the stack. E. 
an example plot, from the same trials as panels A-D, showing calcium fluorescence 
dynamics cross 20 minutesFigure 9. a. The structure of the mitochondrion illustrating the 
low pH of the intramembrane space and the high pH of the matrix. b. Represents the 
mitochondrial permeability transition pore. The low conductance state shows a low flow of 
calcium ions exiting the matrix to the cytoplasm. The high conductance state illustrates a 
high flow of calcium ions exiting the matrix, along with the release of the protein CypD 
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Interaction of DOPAL with the Mitochondrial PTP.  During the metabolic 
breakdown of DA into DOPAL by MAO-A, H2O2 is formed as well. DOPAL interacts 
with H2O2 forming free radicals (Burke et al., 2004). MAO-A is active on the cytosolic 
face of the mitochondrial membrane less than 50 nm away from the mitochondrial PTP 
(Burke et al., 2004). Concentrations of DOPAL as low as 125 nM create enough free 
radicals to induce the high conductance state of the mitochondrial PTP, resulting in 
apoptosis (Burke et al., 2004). The temporal location of free radicals formation relative to 
the PTP allows for the free radicals to easily interact with the pore. This points to a 
potential therapeutic target for PD namely, preventing the mitochondrial PTP from 
entering its high conductance state by forcing the PTP to stabilize into its low 
conductance state. 
Paraxanthine as a Neuroprotectant 
Approximately 80% of caffeine gets metabolized into paraxanthine in the liver 
(Benowitz, Jacob, Mayan, & Denaro, 1995). It is important to note caffeine does not get 
metabolized during its first pass through the liver (Arnaud, 1993). Caffeine is both 
hydrophilic and lipophilic (Bonati, Latini, Galletti, Young, Tognoni, & Garattini, 1982). 
Caffeine and paraxanthine share many pharmacological properties and actions, including 
lipophilic properties (Denaro, Brown, Wilson, Jacob, & Benowitz, 1990). These 
properties allow caffeine and paraxanthine to freely pass through all biological 
membranes and the blood-brain barrier through simple diffusion and saturable carrier-
mediated transport (Arnaud, 2011; McCall, Millington, & Wurtman, 1982; Verkhratsky, 
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2002). Approximately 80% of caffeine passes into the brain during its first circulatory 
pass (Oldendorf, 1971).  
 Studies have shown that the consumption of caffeine is negatively correlated with 
risk for PD (Ascherio et al., 2001; Kalda, Yu, Oztas, & Chen, 2006; Xu et al., 2010). This 
link has been supported by experimental studies, showing caffeine and its metabolites 
have neuroprotective effects against PD-related toxicity such as that caused by exposure 
to the selective DA neuron toxin, MPTP (Xu et al., 2002; Xu et al., 2010).  
The neurotoxin MPTP is the metabolic precursor to the biologically active 
molecule MPP+. MPTP is the gold standard for modeling PD as it induces similar 
pathologies similar to those seen in PD in humans. Once MPP+ reaches DA neurons, it 
interferes with mitochondrial complex I of the electron transport chain inducing 
permanent Parkinsonian symptoms (Smeyne & Jackson-Lewis, 2005).  
Originally, the neuroprotective effects of caffeine and paraxanthine were thought 
to result from inhibition of adenosine receptors (Ascherio et al., 2001; Checkoway et al., 
2002; Chen et al., 2001; Kalda et al., 2006). However, research suggests the 
neuroprotective effects are directly related to the opening of ryanodine receptors, Ca2+ 
release channels, and the subsequent rise in intracellular Ca2+ concentration (Guerreiro et 
al., 2008). Ryanodine receptors are Ca2+ release channels located on the ER (Fill & 
Copello, 2002; Verkhratsky, 2006). 
Guerreiro et al. (2008) modeled PD through MPP+ exposure in differentiated 
midbrain DA cells in a culture. Examining the dose-dependent neuroprotective effects of 
caffeine and paraxanthine, they showed equal concentrations of paraxanthine had a 
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significantly larger neuroprotective effect than caffeine. This is suggestive that the 
neuroprotective effect of caffeine is, in part or in full, due to its metabolite paraxanthine. 
The neuroprotective effect is caused by ryanodine receptor activation, rather than 
adenosine receptor blockade. Activation of ryanodine receptors, using the agonist 
dantrolene, exhibited similar neuroprotective effects when compared to paraxanthine. 
Whereas blockade of ryanodine receptors, using a ryanodine receptor antagonist, 
prevented the neuroprotective effects. Paraxanthine mediated activation of ryanodine 
receptor results in a moderate elevation of intracellular cytosolic free calcium (Cacyt
2+) 
levels. A large increase in Cacyt
2+ did not have a neuroprotective effect, suggesting the 
Cacyt
2+ concentration needs to be elevated just above normal levels to have a 
neuroprotective effect.  
 Paraxanthine is most neuroprotective being treated for 10 days continuously after 
MPP+ exposure at concentrations between 800 - 1000 µM treated in differentiated brain 
cells. The researchers identified neuroprotection by quantifying cells expressing tyrosine 
hydroxylase, the enzyme responsible for synthsizing L-DOPA. The paraxanthine 
treatment group showed 194% more TH cells in the culture over the control group. 
Critically, the degree of intracellular Ca2+ increases was correlated with the number of 
preserved dopaminergic neurons. The preserved dopaminergic neurons also retained 
basic functioning such as the synthesis, release, and uptake of DA.  
 While these experiments provided compelling evidence of the mechanism of 
neuroprotection by caffeine, it must be emphasized that in this in vitro study the neurons 
were exposed to much higher paraxanthine concentrations that would be expected after 
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ingestion of caffeine in living animals (Burke et al., 2004). The authors note it would be 
expected to see similar effects in vivo when exposed to lower concentrations (Guerreiro 
et al., 2008). 
Role of Intracellular Calcium in the Neuroprotective Effects of Caffeine 
 Calcium overview. Calcium is an important signaling molecule used in many 
aspects of cell regulation. The fluctuation of Ca2+ regulates cell excitability, synaptic 
plasticity, neurotransmitter release, gene regulation, and apoptosis (Fill & Copello, 2002; 
Mattson, 2012; McConkey & Orrenius, 1997; R. Rizzuto et al., 2012; Usachev, Shmigol, 
Pronchuk, & Verkhratsky, 1993). Ca2+ is widely recognized as the most important 
signaling molecule and is highly regulated in neurons (Mattson, 2012).  
Elevations of intracellular Ca2+ levels are necessary for cell signaling, however 
prolonged increases in Ca2+ can result in cell death (Hongpaisan, Winters, & Andrews, 
2004; Ichas & Mazat, 1998; McConkey & Orrenius, 1997; Orrenius et al., 2003; Rizzuto 
et al., 2003). Ca2+ signaling requires cells to signal using brief elevations of Ca2+ levels 
followed by a rapid decay, commonly known as Ca2+ oscillations (Berridge, Lipp, & 
Bootman, 2000; Dupont, Abou-Lovergne, & Combettes, 2008). There are three types of 
Ca2+ encoding are amplitude modification (AM), frequency modification (FM), and 
amplitude and frequency modification (AFM) (De Pitta, Volman, Levine, & Ben-Jacob, 
2009). With AM encoding, the strength of the stimulus is encoded by changes in 
amplitude while frequency remains constant. FM encoding encodes the strength of the 
stimulus in varying frequencies while the amplitude remains the same. AFM encoding is 
a combination of AM and FM encoding, where the strength of the stimulus is encoded in 
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a blend of changes in both frequency and amplitude. They type of encoding a cell uses 
varies based on the type of cell. 
 Cells are suspended in a high Ca2+ concentration (in the mM range) extracellular 
environment (Fill & Copello, 2002; McConkey & Orrenius, 1997). Resting free Ca2+ 
concentration within the cytoplasm is much lower (approximately 100 nM range) than the 
extracellular environment (Berridge et al., 2000; Fill & Copello, 2002; McConkey & 
Orrenius, 1997). The cytoplasm is filled with Ca2+ buffering and binding proteins to 
prevent large influxes of Ca2+ inducing apoptosis (Fill & Copello, 2002; Verkhratsky, 
2005). 
 Calcium in the Endoplasmic Reticulum. The ER is the largest intracellular 
organelle present in all nerve cells and is recognized as the most prominent storage 
facility for Ca2+ ions (Rizzuto et al., 2012, Verkhratsky, 2005). Neurons use changes in 
Ca2+ levels as an intracellular signal in many cellular functions such as second 
messengers by activating protein kinases, trigger synaptic vesicle exocytosis, and trigger 
apoptosis (Brose, Petrenko, Sudhof, & Jahn, 1992; Hongpaisanet al., 2004; McConkey & 
Orrenius, 1997; Orrenius et al., 2003; Rizzuto et al., 2003; Rizzuto et al., 2012). In 
neurons, the ER extends throughout dendrites, axons, and soma (Verkhratsky, 2006). 
Changes in local concentrations of intracellular Ca2+ are able to induce signals that 
diffuse throughout the cell and elicit cellular processes at a remote location (Rizzuto et 
al., 2012).  
There are two main types of Ca2+ release channels on the ER: Ryanodine 
receptors and Inositol trisphosphate receptors (Verkhratsky, 2006). Ryanodine receptors 
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are large transmembrane proteins located on the outer face of both the smooth and rough 
ER (Blaustein & Golovina, 2001; Fill & Copello, 2002). Ryanodine receptor channels are 
large conductance Ca2+ channels that are able to move large numbers of Ca2+ ions (Fill & 
Copello, 2002). This large efflux of Ca2+ from the ER allows for highly concentrated Ca2+ 
‘hotspots’ to form between the ER and mitochondria. Ryanodine receptors control Ca2+ 
flow in a bell-shaped dose-dependent fashion meaning activation of the receptors reliably 
release Ca2+ in a bell shaped curve (Bezprozvanny, Waltras, & Ehrlich, 1991; Fill & 
Copello, 2002; Verkhratsky, 2005). Ryanodine receptors are inactive when exposed to 
nM and mM concentrations of ryanodine receptor agonists, but active while exposed to 
μM concentrations (Bezprozvanny et al., 1991). This feature of ryanodine receptors 
allows the testing of varying concentrations of paraxanthine to find the ideal 
concentration for neuroprotection.  
Inositol trisphosphate receptors and ryanodine receptors each have a unique way 
of releasing Ca2+ as a cellular signal. Inositol trisphosphate receptors cause Ca
2+ to release 
in small ‘puffs’. These ‘puffs’ produce diverse amplitudes resulting from a varying 
number of channels opening within a cluster (Berridge et al., 2000). This suggests 
activation of inositol trisphosphate receptors affect AM encoded Ca2+ signaling. 
Ryanodine receptors cause Ca2+ to release in ‘sparks’. These ‘sparks’ occur when a 
cluster of ryanodine receptors open in unison causing a spontaneous spike of Ca2+ to be 
released (Berridge et al., 2000, Cheng, Lederer, & Cannell, 1993). This suggests 
activation of ryanodine receptors affect FM encoded Ca2+ signaling.  
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Approximately 80% of ryanodine receptors are found facing the cytoplasm, 
suggesting a release of Ca2+ from the ER into the cytoplasm (Verkhratsky, 2002). Free 
Ca2+ ions cannot travel further than 500 nm before being bound by calreticulin, the main 
Ca2+ binding protein in neurons, rendering the Ca2+ unable to make cellular changes. 
(Verkhratsky, 2002). This allows for isolated Ca2+ microdomains within the cytoplasm 
before becoming inactivated through a Ca2+ binding proteins. 
  A study showed 80% of mitochondria were found to be in contact with the ER 
(Cascarano, Montisano, Pickett, & James, 1982; Copeland & Dalton, 1959). Using GFP 
labeling of organelles, a study identified the mitochondria and ER were found to be 
localized at less than 200 nm apart (Rizzuto et al., 1998).  This localization was labelled 
the mitochondria associated membrane (MAM) (Rizzuto et al., 1998). The ER and MAM 
play a pivotal role in Ca2+ exchange into the mitochondria through ryanodine receptors 
and inositol trisphosphate receptors. The MAM allows for Ca2+ ‘hotspots’ to form so 
signaling between the ER and mitochondria occurs without interruption of Ca2+ binding 
proteins. This allows for adequate functioning of mitochondrial metabolism and is a 
determinant in cell life and death (Cascarano et al., 1982; Ichas & Mazat, 1998; Kluck et 
al., 1997; Patergnani et al., 2011; Raturi & Simmen, 2013). 
Mitochondria sense these localized ‘hotspots’ of Ca2+ and rapidly uptake the Ca2+. 
The mitochondria react to the Ca2+ ‘hotspot’ as normal cellular Ca2+ signaling (Ichas & 
Mazat, 1998). The fast rate of Ca2+ uptake triggers the mitochondrial PTP to open under a 
low conductance state. (Ichas & Mazat, 1998). Administering caffeine and paraxanthine 
will cause Ca2+ ‘hotspots’ to form within the MAM. This treatment will artificially force 
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the PTP into stabilizing into its low conductance state preventing PTP mediated 
apoptosis. Manipulating the mitochondria PTP may be a new therapeutic target to treat 
PD patients in the future.  
Zebrafish as a Model Organism in PD Research 
General. The zebrafish, Danio rerio, have emerged as a leading model organism 
for drug discovery and toxicology research. The zebrafish is small in size and easy to 
house in large numbers. They provide simple detection of target phenotypes making them 
essential for high-throughput screening (Zon & Peterson, 2005). Using a whole organism 
allows researchers to answer biological questions that cannot be addressed in vitro (Zon 
& Peterson, 2005). The zebrafish provide a high degree of genetic and physiological 
similarity to mammals. The zebrafish’s forebrain dopaminergic nucleus is a homolog of 
mammalian midbrain dopaminergic system (Lam, Korzh, & Strahle, 2005). As well as, 
amino acid sequence conservation of proteins between mammals and the zebrafish 
suggest similar protein functions (Ahmad, Noldus, Tegelenbosch, & Richardson, 
2012).  This is indicative of a high conservation in drug response between and humans, 
estimated around 95% (Zon & Peterson, 2005).  
 Zebrafish embryos and larvae have transparent skin. This feature makes it 
possible to detect functional and morphological changes in internal organs without killing 
or dissecting the organism. Transparent skin allows the use of Ca2+ imaging with 
fluorescent dye to quantify changes in Ca2+ concentration within the neurons of intact 
zebrafish larvae.  
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 Caffeine, in non-chronic dosing, affects locomotor behaviors in a dose-dependent 
fashion (Holtzman, 1989).  Examining the swimming speeds in caffeine treated (10, 25, 
50 mg/L) zebrafish, showed that at 25 mg/L and 50 mg/L concentration caused a 
decrease in swimming speed (Ladu et al., 2015). It is important to note our experiment 
will be using much lower concentrations of caffeine. However, there is no change in 
swimming behaviors in concentrations less than 100 µM (Abdelkader, Chang, Kim, 
Song, Kim, & Park, 2013; Capiotti et al., 2011).  
 Zebrafish larvae have an average baseline heart rate of approximately 130 bpm 
(SD = 6.3) (Burns, Milan, Grande, Rottbauer, MacRae, & Fisherman, 2005). Caffeine 
concentrations of 100 µM, exposed to zebrafish embryos, significantly increased heart 
rate (Abdelkader et al., 2013). This study measured heart rate immediately after 
administration and at 48, 72, and 96 hours post fertilization (hpf). The average heart rate 
in the control group was 110, 110, and 112 bpm at 48, 72, and 96 hpf respectively. The 
average heart rate in the 100 µM group was 122 at 72 hpf and 136 at 96 hpf. It is 
important to note this study was conducted in zebrafish embryos. The planned 
experiment will be using zebrafish larvae so heart rate is expected to be higher than the 
embryos.  
 
  
ARE CAFFEINE’S EFFECTS ON NEURONAL CALCIUM LEVELS DUE TO THE 
CAFFEINE METABOLITE, PARAXANTHINE? 24 
 
Statement of the Problem 
Evidence shows that paraxanthine exhibits neuroprotective effects in vitro 
(Guerreiro et al., 2008; Xu et al., 2002; Xu et al., 2004). This study was designed as 
another step toward developing information needed to evaluate the potential for clinical 
applications of paraxanthine neuroprotection, by examining parathanxine effects on 
neurons in an in vivo vertebrate model system.  Specifically, I examined effects of 
paraxanthine and caffeine in living zebrafish larvae to determine whether these drugs 
have equivalent, dose-dependent effects on neuronal calcium dynamics, locomotor 
activity, and heart rate. I did not directly assess neuroprotective effects of caffeine or 
paraxanthine. Instead, this study was intended to obtained baseline dose-response 
information on these drugs to inform future neuroprotection studies.  
Hypotheses 
 Hypothesis 1.  Bath application of paraxanthine and caffeine will increase the 
amplitude of calcium oscillations from forebrain dopamine neurons in 5 dpf zebrafish in 
a dose-dependent manner.  
Hypothesis 1a. Amplitude of calcium oscillations during successive 20-minute 
imaging blocks will significantly increase as paraxanthine concentration in the bath 
solution is increased from 0 to 40 µM to 100µM to 200 µM. 
 Hypothesis 1b. Amplitude of calcium oscillations during successive 20-minute 
imaging blocks will significantly increase as caffeine concentration in the bath solution is 
increased from 0 to 50 µM to 125 µM to 250 µM. 
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 Hypothesis 1c. Similar amplitudes will be found for the effects of paraxanthine 
and caffeine on intracellular calcium oscillations. 
Rationale for Hypothesis 1. Paraxanthine is an agonist for ryanodine receptors, 
ER calcium release channels. Paraxanthine is a main metabolite of caffeine, so I reasoned 
that a comparable amount of either drug should both produce similar changes in calcium 
oscillations. The forebrain dopamine nucleus that was imaged is a putative homolog of a 
mammalian catecholamine nucleus, the locus coeruleus, that is affected in PD (Lam et 
al., 2005). 
Hypothesis 2. Bath application of paraxanthine and caffeine will increase 
visually-evoked (light-dimming-evoked) intracellular calcium responses in forebrain 
dopamine neurons in 5 dpf zebrafish in a dose-dependent manner. These hypotheses 
paralleled Hypotheses 1a-1d but examined neuronal calcium increases evoked by a visual 
stimulus rather than examining resting calcium levels. These hypotheses were tested in 
the same group of animals by presenting the sensory stimulus twice at the end of each 20-
minute imaging block using to measure resting calcium.  
Hypothesis 2a. The size of visually-evoked calcium responses (measured as the 
percentage change in fluorescence intensity from before to immediately after the 
stimulus) will significantly increase as paraxanthine concentration in the bath solution is 
increased from 0 to 40 µM, to 100µM to 200 µM. 
Hypothesis 2b. The size of visually-evoked calcium responses will significantly 
increase as caffeine concentration in the bath solution is increased from 0 to 50 µM to 
125 µM to 250 µM.  
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 Hypothesis 2c. A similar dose-response function (slope) will be found for the 
effects of paraxanthine and caffeine on the size of visually-evoked calcium responses. 
Rationale for Hypothesis 2. Paraxanthine is an agonist for ryanodine receptors, 
ER calcium release channels. Paraxanthine is a main metabolite of caffeine, so the 
comparable amount of should both produce similar increases in calcium. Previous studies 
determined that light dimming reliably evoked action potentials within these neurons in 
untreated zebrafish larvae. Calcium is increased inside neurons for up to 1s when an 
action potential is fired (Grienberger & Konnerth, 2012). An increase in fluorescence 
immediately following the visual stimulus was therefore considered as a stimulus-evoked 
neuronal response. 
Hypothesis 3. Bath application of paraxanthine and caffeine will increase resting heart 
rate in 5 dpf zebrafish larvae. 
Hypothesis 3a. Bath application of 200 µM Paraxanthine for 20 minutes will 
increase heart rate 5 minutes later. 
Hypothesis 3b. Bath application of 250 µM Caffeine for 20 minutes in 5 dpf 
zebrafish larvae will increase heart rate 5 minutes later. 
Hypothesis 3c. Bath application of Paraxanthine or Caffeine for 20 minutes in 5 
dpf zebrafish larvae will have a similar affect heart rate. 
Rationale for Hypothesis 3. Caffeine administration increases heart rate in the 
zebrafish (Abdelkader et al., 2013). Paraxanthine is the main metabolite of caffeine. By 
using a metabolically equivalent ratio of paraxanthine to caffeine, I reasoned that the 
larvae should show the same behavioral effects. Heart rate was measured in this 
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experiment as a manipulation check because if the drug application procedure worked as 
expected a change in heart rate should occur. 
Hypothesis 4. Bath application of paraxanthine and caffeine will decrease 
spontaneous swimming activity (measured as the percentage of time spent in motion 
during a 20-minute observation period) in 5 dpf zebrafish larvae in a dose-dependent 
manner. 
Hypothesis 4a. Swimming activity will significantly decrease as paraxanthine 
concentration in the bath solution is increased from 0 to 40 µM to 100 µM to 200 µM. 
Hypothesis 4b. Swimming activity will significantly decrease as caffeine 
concentration in the bath solution is increased from 0 to 50 µM to 125µM to 250 µM. 
Hypothesis 4c. Changes in spontaneous swimming activity will remain similar 
between the caffeine and paraxanthine treated zebrafish. 
 Rationale for Hypothesis 4. Acute caffeine dosage decreases active voluntary 
behaviors, such as spontaneous swimming behaviors, in a dose dependent manner 
(Holtzman, 1989; Ladu et al., 2015). Paraxanthine is the main metabolite of caffeine. By 
using a metabolically equivalent ratio of paraxanthine to caffeine I reasoned that the 
larvae should show the same behavioral effects. This thesis focused on cellular 
mechanisms of caffeine and paraxanthine but it is important to measure behavioral effects 
of these drugs because much of PD research with zebrafish uses swimming behaviors as a 
secondary measure of dopaminergic cell death, and future paraxanthine neuroprotection 
studies would be expected to use both neuronal and behavioral measures of function.  
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Method 
Subjects  
 Zebrafish are housed and bred on the HSU campus in BSS 122 F. Animals care 
and breeding procedures are described in detail in a facility manual (standard operating 
procedures) that has been filed with the Humboldt State University IACUC for this 
zebrafish facility. For the current study approximately 10 adult zebrafish from the 
existing colony (approximately 5 male and 5 female) will be used as brood stock to 
generate larvae for experimentation. Approximately 105 larvae, ages 4-8 days post 
fertilization, will be used in experiments.  
 At 5 days post fertilization (dpf), larvae will be randomly assigned to one of three 
conditions, consisting of 8 larvae each. Prior research on calcium response in zebrafish 
neurons (n = 27) found a minimum of a 10% change in fluorescence within 24 cells when 
compared to baseline measurements (Gahtan, Sankrithi, Campos, &O’Malley, 2002).  
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Table 1  
Experimental Design and Dosages 
 Caffeine Paraxanthine 
Control N/A N/A 
Caffeine – Low 50 µM N/A 
Caffeine – Med 125 µM N/A 
Caffeine - High 250 µM N/A 
Paraxanthine – Low N/A 40 µM 
Paraxanthine – Med N/A 100 µM 
Paraxanthine – High N/A 200 µM 
Note. The study design is a 2x3 mixed factorial experiment with repeated measures. 
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Table 1 shows the first factor is drug type, with two levels, caffeine and paraxanthine, 
compared between subjects. The second factor is drug concentration, with three levels (a 
low, intermediate, and high concentration of each drug) compared within subjects. There 
are four dependent measures: the first measure, resting neuronal calcium fluorescence, 
measured as the percent of pre-drug fluorescence intensity, the second measure, sensory-
evoked neuronal calcium responses using a dark-flash stimulus and measured in neurons 
known to be activated during dark-flash responses, the third measure, spontaneous 
swimming activity, and the fourth measure, sensory-evoked swimming activity using a 
dark-flash stimulus. The same animals were used to measure both spontaneous and 
evoked calcium levels (measures one and two) and calcium fluorescence was measured 
repeatedly in the same animals. A different group of animals were used for behavioral 
measures (the same group for spontaneous and evoked swimming activity), and 
measurements of swimming behavior were also made repeatedly within animals across 
drug concentrations. 
 Multiple neurons within the target nucleus can be recorded simultaneously in a 
single animal and I had originally proposed analyzing each imaged neuron as a separate 
observation (I performed a statistical power analysis to determine that each group should 
include at least 8 neurons measured across at least 4 animals, to achieve statistical power 
of at least .80, assuming a large effect size). However, resolving individual neurons 
proved to be unreliable in the recorded images, so instead each nucleus was analyzed as a 
single observation. In preparations where both sides of the brain could be resolved clearly 
in the same image, I recorded two nuclei per animal, but in most preparations only one 
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nucleus was recorded. In total, 25 nuclei were imaged across 15 larvae and 14 of those 
nuclei were included in the final statistical analysis.  
Instruments and Software 
 Data from zebrafish behavior will be captured using two cameras. The high speed 
PTEM Photon Focus camera and the time lapse Pixelink camera. These will be used to 
obtain behavioral data from stimuli sent by a LabJack controlled program with 
DAQFactory. The images obtained will be analyzed by a custom script to be run through 
ImageJ. Images of dopaminergic cells and calcium signaling will be taken with an 
Olympus Fluoview FV1000 confocal microscope using the appropriate lens.  
Procedures  
 Calcium imaging. I proposed using one of two methods for fluorescent calcium 
imaging in zebrafish neurons, either by first injecting a calcium-sensitive fluorescent dye 
into neurons, or by using a transgenic zebrafish line with a genetically-encoded 
fluorescent calcium indicator (GECI) protein expressed in neurons. The GECI line was 
the preferred option and I was able to obtain a suitable zebrafish line, called 
elavl3:GCaMP6s (doi:10.1038/nmeth.3040), from the lab of Florian Engert at Harvard 
(after securing required permissions from both universities). This line expresses a GECI 
in most brain neurons under the control of the elavl3 gene, which is a transcription factor 
expressed in newly differentiated neurons. Therefore, no injections were done, and all 
calcium imaging was performed in 5 days post fertilization (dpf) GCaMP6s larvae that 
were confirmed to have inflated swim bladders (a sign of general health). 
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 Larvae are prepared for calcium imaging by first being embedded in low-melting 
temperature agarose (ThermoFisher; 1.2% dissolved in egg water). Larvae are place with 
a transfer pipette onto a clean plastic surface in a small drop of egg water and then re-
aspirated into a new pipette containing about 1ml of the melted agar solution (at about 28 
deg C). Once suspended in the agar the larva is dripped onto a microscope cover slide, 
where within 20 seconds it will be immobilized (usually in the desired dorsal-up posture) 
within the hardening agar. The cover slip is then inserted into a custom imaging chamber 
that allows the agar holding the larva to be in contact with a fluid solution that can be 
changed rapidly and remotely, thus allowing different drug solutions to be introduced 
during the imaging session without moving the larva (once in contact with the porous 
agar, drug solutions diffuse through the agar, contact the larva’s skin, and are taken up 
through the skin to the larva’s blood circulation. The imaging chamber is then clamped 
onto the heated stage plate (maintained at 23 deg C) of the confocal microscope. An 
Olympus FV1000 confocal system with a 20x .95NA water immersion objective will be 
used for imaging calcium indicator fluorescence. First, a cell of interest will be identified 
and documented in a saved anatomical reference image. The cells of interest include any 
of the glutamatergic descending neurons in the hindbrain ( Kinkhabwala et al., 2011). 
The image will be optically magnified so the cell occupies the central portion of the 
imaging area. To assess baseline fluorescence the confocal will be set to automatically 
acquire an image of the cell once every 10 seconds for 10 minutes (an imaging block). 
The normal egg water in the imaging chamber will then be removed and replaced with 
egg water containing 50 µM caffeine, and another 10 min imaging block will be run. Two 
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more imaging blocks will follow, changing the caffeine solutions between each, first to 
125 µM and finally to 250 µM. These concentrations of caffeine were determined from 
previous research that examined zebrafish larvae responses to caffeine (Abdelkader et al., 
2013). Four imaging blocks will also be run in paraxanthine experiments, with the 
solution changed between blocks as follows: 0, 40 µM, 100 µM, and 200 µM. 
Administration of paraxanthine in the zebrafish have yet to be documented. Paraxanthine 
concentrations were determined by using proportions based on caffeine metabolic 
pathway concentrations. After imaging the larva will be de-embedded from the agar 
(done with fine tools under a dissecting microscope) and returned to an individual 35mm 
petri dish containing approximately 3ml of regular egg water. Approximately 24 hours 
after the calcium imaging experiment larvae will be assessed for mortality so that 
potential toxicity from the previous drug exposures might be detected, and following this 
assessment all larvae still living will be euthanized by immersion in 0.03% tricaine 
methanesulfonate for 10-20 minutes following cessation of opercular movement. 
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Table 2 
 Timeline for Calcium Imaging Experiments 
Condition Data Acquired Time for 
Procedure 
Cumulative 
Time 
Control (pre-drug) Heart rate imaging 2min 2 min 
 Spontaneous Ca2+ imaging 20 min 22 min 
 Dark flash Ca2+ imaging 
trials  
4 min 26 min 
50μM Caffeine or Heart rate imaging 2min 28 min 
40μM Paraxanthine Spontaneous Ca2+ imaging 20 min 48 min 
 Dark flash Ca2+ imaging 
trials  
4 min 52 min 
125μM Caffeine or Heart rate imaging 2min 54 min 
100μM Paraxanthine Spontaneous Ca2+ imaging 20 min 74 min 
 Dark flash Ca2+ imaging 
trials  
4 min 78 min 
250uM Caffeine or Heart rate imaging 2min 80 min 
200uM Paraxanthine Spontaneous Ca2+ imaging 20 min 100 min 
 Dark flash Ca2+ imaging 
trials  
4 min 104 min 
Note.  Each larva received all concentrations within caffeine and paraxanthine 
groups. All control, caffeine, and paraxanthine solutions also contained 100μM d-
tubocurarine to prevent movement during imaging. Solutions were changed 
manually between imaging blocks using a plastic pipette.  Agar-embedded larvae 
were bathed in approximately 2ml of each solution during image. N = 15 nuclei in 
eight larvae for the caffeine group, and N = 11 nuclei in six larvae for the 
paraxanthine group. 
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 Spontaneous Locomotor Behavioral Swimming Test. Larvae, at 6 dpf, will be 
individually transferred, via plastic pipette, into 10mm wells containing 4 mL of egg 
water positioned above a digital camera. The camera will be programmed to take images 
at 1 Hz for 10 minutes each hour for a duration of six hours. The camera utilizes an 
infrared light source, otherwise the experiments will be conducted in darkness to avoid 
any vision mediated influences on locomotor behaviors. Post recording, larvae will be 
pipetted back into a 60mm petri dish and housed in the incubator. 
 Behavior Analysis. At 6 dpf, larvae will be moved to singular 10 mm wells 
holding 4 mL of egg water for imaging of behavioral activity. Spontaneous locomotor 
time lapse recordings will be taken over the course of 6 hours for each group to be used 
as a baseline. Using a custom script to quantify activity, the stacked images will be 
subtracted from each other. This will leave us a new video only showing pixels that have 
changed over the course of the 6 hours, thus providing us with just the fish’s swimming 
behavior. A custom script will then provide an analysis of the fish’s locomotor activity in 
each well providing us with percent of time the fish was in motion during the recording 
period.  
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Figure 10. Quantification of spontaneous calcium fluorescence. A. Raw confocal video stack 
consisting of 6,000 frames. B. Projection of average pixel values across the stack. Arrow 
heads show individual neuron cell bodies the tart nucleus that can be resolved. C. Threholded 
image showing isolation of the target nucleus as a density (particle) of blue pixels. A smaller 
particle in the upper right of the image is not included because of a size cut off. D. Isolated 
region of interest for subsequently measuring each from in the stack. E. an example plot, from 
the same trials as panels A-D, showing calcium fluorescence dynamics cross 20 minutes 
 
 
Figure 11. Example of a visually-evoked calcium imaging trial. A-D. Confocal time lapse 
projection showing average fluorescence intensity during 4 seconds at the start of the trial 
scan (A), immediately before the dark flash stimulus (B), immediately after the stimulus (C), 
and at the end of the scan (D). E. The corresponding fluorescence intensity plot. Colored 
boxed indicate the time periods shown in A-D. Calculations of ΔF from fluorescence intensity 
before and after stimulus onset is shown.Figure 12. Quantification of spontaneous calcium 
fluorescence. A. Raw confocal video stack consisting of 6,000 frames. B. Projection of 
average pixel values across the stack. Arrow heads show individual neuron cell bodies the tart 
nucleus that can be resolved. C. Threholded image showing isolation of the target nucleus as a 
density (particle) of blue pixels. A smaller particle in the upper right of the image is not 
included because of a size cut off. D. Isolated region of interest for subsequently measuring 
each from in the stack. E. an example plot, from the same trials as panels A-D, showing 
calcium fluorescence dynamics cross 20 minutes 
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 Heart Rate. Larvae will be embedded in a low melting point agar on a 
microscope slide. The larvae will not be anesthetized, as we will be analyzing the 
treatment’s effects on heart rate. This require unimpaired functioning of the nervous 
system. The larvae will be placed under a microscope to record heart rate 1 minutes. A 
stage warmer is unnecessary as the larvae will spend a total time under the microscope of 
approximately 5 minutes. The larvae will be removed from the agar and placed into a 
60mm petri dish with standard egg water. The petri dish will be housed in an incubator 
(temperature of 28.5° C; 12h/12h light/dark cycle). 
Analyses 
  Spontaneous calcium dynamics. To draw a region of interest (ROI) around the 
target nucleus for analysis, each 20 minute video, consisting of 6,000 frames (5 images 
per second for 20 minutes), was first merged into a single averaged frame (averaged 
value of each pixel across images). The averaged frame was then thresholded into a 
binary image that isolated the nucleus as a group of pixels. That pixel group was saved as 
a ROI file and then applied to each frame of the video to measure fluorescence brightness 
within that region (Figure 4).  
 I had originally intended to analyze drug effects on fluorescence brightness as a 
secondary indicator of intracellular calcium levels. However, because successive 20min 
imaging blocks were separated by blocks of heart rate imaging, the viewing field had to 
be moved (from the brain to the heart) and microscope settings changed, and upon 
returning to the brain nucleus I could not be sure that absolute fluorescence brightness 
was directly comparable to the previous imaging block. Therefore, I analyzed drug 
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effects on fluorescence dynamics within imaging blocks, rather than on brightness. 
Specifically, I examined the power (amplitude) of fluorescence oscillations at specific 
frequencies within each 20 min imaging block. Spontaneous, low frequency (<5Hz) 
calcium oscillations are common in neural circuits across species and can be altered by 
drugs and neurological disease states (Kastanenka et al., 2017), therefore, it is a relevant 
indicator of caffeine and paraxanthine effects on neurons in the current study. The 
imaging parameters used in this study (5 Hz for 20 minutes) limited analysis to 
oscillation frequencies ranging from 0.001 to 2.5 Hz. A spectral analysis of brightness 
values was performed in Matlab to determine the mean power spectral 
density (amplitude) in each of the following 5 frequency analysis bins (bins were 
determined a priori based on constraints of the data and previous research; (Ashworth & 
Bolsover, 2002; Romano, Peitri, Perrez-Schuster, Jouary, Haudrechy, & Sumbre, 2015, 
Smeyne & Jackson-Lewis, 2005): 0.001 – 0.01 Hz, 0.01 – 0.05 Hz, 0.05 – 0.1 Hz, 0.1 – 1 
Hz, 1-2.5 Hz.  
ARE CAFFEINE’S EFFECTS ON NEURONAL CALCIUM LEVELS DUE TO THE 
CAFFEINE METABOLITE, PARAXANTHINE? 39 
 
 
  
Figure 13. Example of a visually-evoked calcium imaging trial. A-D. Confocal time lapse 
projection showing average fluorescence intensity during 4 seconds at the start of the trial scan 
(A), immediately before the dark flash stimulus (B), immediately after the stimulus (C), and at 
the end of the scan (D). E. The corresponding fluorescence intensity plot. Colored boxed 
indicate the time periods shown in A-D. Calculations of ΔF from fluorescence intensity before 
and after stimulus onset is shown. 
 
Figure 14. Example of behavioral analysis procedures for a single 20 minute spontaneous 
activity trial followed by a 1 minute startle trial (taken from a control condition recording). A. 
Raw image stack of larvae in behavior recording wells. Caffeine and Paraxanthine larvae from 
the same clutch were tested at the same time to avoid confounds. B. Images have been 
processed by background subtraction and thresholding and circular regions of interest 
manually drawn around each well (ROI numbers appear at the center of each well and the 
larvae can also be seen inside most of the wells as a smaller pixel density). C. Projection of 
maximum pixel intensity at each pixel across all 1260 images showing the positions occupied 
by the larvae across time. The red circle indicates the well for which data are shown in D and 
E. D. Distance traveled between successive video frames (1 second intervals) across 20 
minutes of spontaneous activity recording followed by a 1 minute dark flash trial. The saw-
tooth pattern indicates the larvae swimming in typical discrete bouts separated by rest periods. 
Activity during dark flash does not appear to be elevated over baseline on this trial. E. The data 
acquired for each behavior recording trial.Figure 15. Example of a visually-evoked calcium 
imaging trial. A-D. Confocal time lapse projection showing average fluorescence intensity 
during 4 seconds at the start of the trial scan (A), immediately before the dark flash stimulus 
(B), immediately after the stimulus (C), and at the end of the scan (D). E. The corresponding 
fluorescence intensity plot. Colored boxed indicate the time periods shown in A-D. 
Calculations of ΔF from fluorescence intensity before and after stimulus onset is shown. 
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 Visually-evoked calcium responses. ROIs around the target neurons were 
generated as described for spontaneous fluorescence analysis. Each startle trial lasted 60 
seconds with the dark flash stimulus occurring after 30 seconds. A normalized index for 
stimulus induced fluorescence change (ΔF) was created by dividing the average 
fluorescence during the four second preceding the stimulus from the average fluorescence 
during the 4 seconds following the stimulus. This ΔF index, corresponding to the 
percentage increase in fluorescence, was the dependent measure analyzed for drug and 
drug concentrations effects on startle trials. Figure 5 shows and example of a visually-
evoked calcium response from the present study. 
 Heart rate. Heart motility was visible in the videos as a pixel contrast oscillations 
within a limited region of the image. An analysis window was manually drawn around 
this pixel region using ImageJ and the average brightness within the region was measured 
on each frame. Brightness values were imported into Microsoft Excel and a formula was 
applied that detected frames that were brighter than both adjacent frames (the adjacent 
frames being those captured 200ms before and 200ms after the target frame), indicating a 
repeated phase of the cardiac rhythm. The number of those repeated phases during the 1 
minute recording was divided by 60 to calculate average beats per second. 
 Swimming behavior. For each drug and dose combination a 1,260 frame 
behavior video was generated that contained 20 minutes of spontaneous swimming 
(1,200 frames) followed by a dark flash startle trial (60 frames). A background 
subtraction method was first applied by subtracting an image that was the averaged pixel 
values across the entire video, from each video frame, creating a new video where each 
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frame highlighted the pixels that identified each larva’s current position. The video was 
then thresholded to set non-target pixels to zero, a procedure that is required for 
automated detection of the XY coordinates of target pixels. An analysis region was drawn 
around dish and the particle analysis function in ImageJ was used to record XY 
coordinates for each larva on each video frame. The distance formula (distance = sqrt (x2 
- x1)2 + (y2 - y1)2) was used in Excel to convert successive XY coordinate pairs into the 
distance traveled by the larvae from frame to frame in units of millimeters per second 
(this was straight forward as the recoding rate was 1 frame per second). From this, the 
measure that was analyzed was total distance traveled across 20 minutes. For startle trials 
a response index was created by dividing the distance traveled during the 60 seconds 
before the startle stimulus from the distance traveled during the following 60 seconds of 
darkness. Figure 6 shows steps of the analysis procedure for an example behavior video.  
. 
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Figure 16. Example of behavioral analysis procedures for a single 20 minute spontaneous 
activity trial followed by a 1 minute startle trial (taken from a control condition recording). 
A. Raw image stack of larvae in behavior recording wells. Caffeine and Paraxanthine 
larvae from the same clutch were tested at the same time to avoid confounds. B. Images 
have been processed by background subtraction and thresholding and circular regions of 
interest manually drawn around each well (ROI numbers appear at the center of each well 
and the larvae can also be seen inside most of the wells as a smaller pixel density). C. 
Projection of maximum pixel intensity at each pixel across all 1260 images showing the 
positions occupied by the larvae across time. The red circle indicates the well for which 
data are shown in D and E. D. Distance traveled between successive video frames (1 
second intervals) across 20 minutes of spontaneous activity recording followed by a 1 
minute dark flash trial. The saw-tooth pattern indicates the larvae swimming in typical 
discrete bouts separated by rest periods. Activity during dark flash does not appear to be 
elevated over baseline on this trial. E. The data acquired for each behavior recording trial. 
 
Figure 17. Startle swimming behaviors categorized by dose received. Control (no drug); 
Low (Caff:50𝜇M/PX:40𝜇M); Med (Caff:125𝜇M/PX:100𝜇M); High 
(Caff:250𝜇M/PX:200𝜇M). Error bars represent the standard error of the mean.Figure 18. 
Example of behavioral analysis procedures for a single 20 minute spontaneous activity 
trial followed by a 1 minute startle trial (taken from a control condition recording). A. Raw 
image stack of larvae in behavior recording wells. Caffeine and Paraxanthine larvae from 
the same clutch were tested at the same time to avoid confounds. B. Images have been 
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Results 
Spontaneous Calcium Dynamics 
 Hypothesis 1 stated that drug type would have similar effects on the amplitude of 
calcium signaling, but the dose would increase the amplitude of the calcium oscillations. 
Data were analyzed using a repeated measures ANOVA with dose (control, low, 
medium, high) as the within-subjects factor and drug type (caffeine, paraxanthine) as the 
between subjects factor. Mauchly’s test indicated that the assumption of sphericity for 
dose has been violated, Χ2 = 11.77, p = .039, so the degrees of freedom were corrected 
using Greenhouse-Geisser estimates of sphericity (ɛ = .665). Calcium oscillation 
amplitude was not significantly affected by drug type, F(1, 12) = 0.161, p = .695, partial 
η2 = .013, when amplitude was examined across all frequencies. Caffeine (n = 7) and 
paraxanthine (n = 7) had the same effect on amplitude.  Drug dose did not affect calcium 
oscillation amplitude, F(1.995, 23.94) = 0.484, p = .622, partial η2 = .039, when 
amplitude was examined across all frequencies. All the doses (n = 12 in each group) 
administered had no effect on calcium signaling.  
 I performed a secondary analysis examining how drug type and dose affected 
each of the frequency bins separately to better understand the effects of dose and drug 
type at individual frequencies. The data were analyzed using repeated measures ANOVA 
with dose (control, low, medium, high) and frequency bin (0.001 – 0.01 Hz, 0.01 – 0.05 
Hz, 0.05 – 0.1 Hz, 0.1 – 1 Hz, 1-2.5 Hz) as the within-subjects factors and drug type 
(caffeine, paraxanthine) as the between-subjects factor. Mauchly’s test indicated that the 
assumption of sphericity for frequency has been violated, Χ2 = 204.046, p < .001, so the 
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degrees of freedom were corrected using Greenhouse-Geisser estimates of sphericity (ɛ = 
.319). There were no significant effects of drug dose on amplitude at any frequency bin 
(bin 1, F(0.957, 11.484) = 0.173, p = .873, partial η2 = .014; bin 2, F(0.957, 11.484) = 
1.311, p = .28, partial η2 = .098; bin 3, F(0.957, 11.484) = 2.056, p = .25, partial η2 = 
.108; bin 4, F(0.957, 11.484) = 2.089, p = .137, partial η2 = .148; & bin 5, F(0.957, 
11.484) = 0.827, p = .453, partial η2 = .065).  
 Drug type also had no effect on amplitude at any frequency bin (bin 1, F(1, 12) = 
0.052, p = .823, partial η2 = .004; bin 2, F(1, 12) = 1.957, p = .145, partial η2 = .140; bin 
3, F(1, 12) = 1.451, p = .25, partial η2 = .108; bin 4, F(1, 12) = 0.731, p = .415, partial η2 
= .056; & bin 5, F(1, 12) = .381, p = .548, partial η2 = .031). Caffeine and paraxanthine 
had the same effects on amplitude within each of the frequency bins. 
There were no interactions between drug type and dose, (bin 1, F(3, 432) = 1.698, 
p = .873, partial η2 = .014; bin 2, F(3, 432) = 1.752, p = .204, partial η2 = .127; bin 3, F(3, 
432) = 1.520, p = .237, partial η2 = .112; bin 4, F(3, 432) = 0.091, p = .530, partial η2 = 
.054; & bin 5, F(3, 432) = 0.733, p = .496, partial η2 = .054). Drug type affected the 
amplitude within each of the frequency bins in the same way at each of the doses 
administered. This is important to report as a significant interaction would suggest 
caffeine and paraxanthine influence calcium signaling differently.  
Evoked Calcium Response 
 The data were analyzed using repeated measures ANOVA with dose (control, 
low, medium, high) as the within-subjects factor and drug type (caffeine, paraxanthine) 
as the between-subjects factor. Mauchly’s test indicated that the assumption of sphericity 
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for dose has not been violated, Χ 2 = 6.143, p = .294. Drug type did not affect the 
average percent change in fluorescence (F), F(1, 12) = 1.657, p = .222, partial η2 = 
.121. This supports our hypothesis and suggests that caffeine and paraxanthine affected 
Ca2+ signaling in the same way. Hypothesis 2 stated that as dose increase, there would 
be an increased percent change in calcium fluorescence. Dose did not affect the average 
F, F(3, 36) = 0.729, p = .503, partial η2 = .057. This indicates that dose did not have an 
effect on Ca2+ signaling. There was not a significant interaction between drug type and 
dose on average F, F(3, 432) = 0.056, p = .982, partial η2 = .005. The interaction 
between dose and drug type met the assumptions for sphericity. The interaction is 
important to report since it provides information supporting there were no differences 
across the average F based on the drug or dose administered.  
 Hypothesis 2c states that there should be a similar response index between the 
drug types tested. The data were analyzed using repeated measures ANOVA with dose 
(control, low, medium, high) as the within-subjects factor and drug type (caffeine, 
paraxanthine) as the between-subjects factor. Mauchly’s test indicated that the 
assumption of sphericity for dose has been violated, Χ 2 = 21.560, p = .001, so the 
degrees of freedom were corrected using Greenhouse-Geisser estimates of sphericity (ɛ = 
.459). Drug type did not significantly affect the response index of the neurons, F(1, 7) = 
0.162, p = .700, partial η2 = .023. Caffeine and paraxanthine had the same effect on the 
response index for Ca2+ signaling after the visually-evoked stimulus. Hypothesis 2 states 
that dose should increase the response index. Dose did not have any effect on the 
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response index, F(1.377, 9.639) = 0.168, p = .792, partial η2 = .023. Increasing dose did 
not affect the calcium response after the visually-evoked stimulus. Dose and drug type 
had no interactions effect on the response index, F(1.377, 67.473) = 0.636, p = .508, 
partial η2 = .083. This supports the idea that caffeine and paraxanthine have similar 
effects on Ca2+ signaling within the neuron. Hypothesis 2 states that drug type will 
produce a similar slope for Ca2+ response after the dimming stimulus.  
Spontaneous Locomotor Behavior  
Hypothesis 4 states that drug type will not affect evoked swimming behaviors; 
however, the dose will decrease spontaneous swimming behaviors. The primary analysis 
investigated swimming behaviors across the 20-minute recording block. The data were 
analyzed using repeated measures ANOVA with dose (control, low, medium, high) as the 
within-subjects factor and drug type (caffeine, paraxanthine) as the between-subjects 
factor. Mauchly’s test indicated that the assumption of sphericity for dose for total 
distance has been violated, Χ2 = 11.435, p = .045, so the degrees of freedom were 
corrected using Greenhouse-Geisser estimates of sphericity (ɛ = .598). Drug type did not 
affect the total distance traveled across the 20 minute recording period, F(1, 10) = 0.070, 
p = .797, partial η2 = .007. Administration of caffeine or paraxanthine did not change the 
total distance swam. Dose did not affect the total distance traveled across the 20-minute 
recording period, F(1.794, 17.942) = 1.142, p = .336, partial η2 = .103. Increasing dose 
did not have an effect on the total distance swam. There was no interaction between dose 
and drug type, F(1.794, 179.42) = 0685, p = .336, partial η2 = .064. Caffeine and 
paraxanthine affected the total distance swam in the same way across all the doses tested. 
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Mauchly’s test indicated that the assumption of sphericity for dose for average 
speed has been violated, Χ2 = 12.184, p = .033, so the degrees of freedom were corrected 
using Greenhouse-Geisser estimates of sphericity (ɛ = .596). Drug type did not affect the 
average speed swam across the 20-minute recording period, F(1, 10) = .018, p = .897, 
partial η2 = .737. Administration of caffeine and paraxanthine affected the average speed 
swam in the same way. Dose did not affect the average speed swam across the 20-minute 
recording period, F(1.787, 17.867) = 1.335, p = .285, partial η2 = .118. Increasing the 
dose did not change the average speed the zebrafish swam. Drug type and dose did not 
have an interaction, F(1.787, 178.67) = 0.881, p = 420, partial η2 = .081. Caffeine and 
paraxanthine affected the average speed swam across all the doses tested. 
Mauchly’s test indicated that the assumption of sphericity for dose for maximum 
speed has been met, Χ2 = 10.206, p = .071, so the degrees of freedom were not corrected. 
Drug type did not affect the maximum speed swam, F(1, 10) = 0.052, p = .824, partial η2 
= .005. Caffeine and paraxanthine did not affect the maximum speed recorded during the 
20-minute recording block. Dose did not affect the maximum speed, F(3, 30) = 2.301, p 
= .097, partial η2 = .187. Increasing doses had not effect on the maximum speed recorded 
during the 20-minute recording block. There was not interaction between drug type and 
dose, F(3, 300) = 0.258, p = .855, partial η2 = .025. Caffeine and paraxanthine affected 
the maximum speed across all the doses tested.  
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A secondary analysis was performed to examine the effects of drug type and dose 
on swimming behaviors on individual time bins that broke up the 20-minute recording 
period into four 5-minute time bins. This allowed us to more closely examine potential 
differences in metabolism rates across varying doses. The data were analyzed using 
repeated measures ANOVA with dose (control, low, medium, high) and time bin (1 – 5, 6 
– 10, 11 – 15, 16 – 20 minutes) as the within-subjects factors and drug type (caffeine, 
paraxanthine) as the between-subjects factor. Mauchly’s test indicated that the 
assumption of sphericity for dose for total distance has been violated, Χ2 = 11.540, p = 
.043, so the degrees of freedom were corrected using Greenhouse-Geisser estimates of 
sphericity (ɛ = .613). Mauchly’s test indicated that the assumption of sphericity for time 
bin for total distance has been violated, Χ2 = 12.615, p = .028, so the degrees of freedom 
were corrected using Greenhouse-Geisser estimates of sphericity (ɛ = .595). Table 3 
shows drug type did not affect total distance traveled, F(1, 10) = 0.003, p = .957, partial 
η2 = .000. Caffeine and paraxanthine affected the total distance swam in the same way. 
Dose did not affect the total distance traveled, F(1.840, 18.401) = 1.178, p = .335, partial 
η2 = .105. Table 4 shows the varying doses administered had not effects on how far the 
fish swam throughout each of the time bins. Table 5 shows time bin had not effect on the 
total distance swam, F(1.784, 17.844) = 0.183, p = .907, partial η2 = .018. There were no 
differences in the total distance swam throughout the time bins. There was no interaction 
between drug type and dose on the total distance swam, F(1.840, 184.01) = 1.126, p = 
.341, partial η2 = .101. Caffeine and paraxanthine affected the total distance swam in the 
same way at each of the varying doses.  
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Mauchly’s test indicated that the assumption of sphericity for dose for average 
speed has been violated, Χ2 = 11.611, p = .042, so the degrees of freedom were corrected 
using Greenhouse-Geisser estimates of sphericity (ɛ = .612). Mauchly’s test indicated 
that the assumption of sphericity for time bin for average speed has been violated, x2 = 
12.273, p = .032, so the degrees of freedom were corrected using Greenhouse-Geisser 
estimates of sphericity (ɛ = .597). Drug type did not affect the average swimming speed 
throughout the time bins, F(1, 10) = 0.003, p = .960, partial η2 = .000. Caffeine and 
paraxanthine did not have an effect on the average speed swam (Table 3). Dose did not 
affect the average speed swam, F(1.837, 18.371) = 1.172, p = .328, partial η2 = .105 
(Table 4). Time bin did not affect the average speed swam, F(1.792, 17.919) = 0.151, p = 
.839, partial η2 = .839. Table 5 shows the average speed remained the same throughout 
the time bins. There was no interaction between drug type and dose, F(1.837, 183.71) = 
1.123, p = .342, partial η2 = .101. Caffeine and paraxanthine affected the average speed 
swam in the same way at each of the varying doses 
Mauchly’s test indicated that the assumption of sphericity for dose for maximum 
speed has been violated, Χ2 = 11.741, p = .040, so the degrees of freedom were corrected 
using Greenhouse-Geisser estimates of sphericity (ɛ = .580). Mauchly’s test indicated 
that the assumption of sphericity for time bin for maximum speed has been met, Χ2 = 
7.999, p = .159. Drug type did not affect the maximum speed swam F(1, 10) = 3.024, p = 
.113, partial η2 = .232. Table 3 shows administration of caffeine or paraxanthine did not 
affect swimming speed. Dose did not affect the maximum swimming speed, F(1.740, 
17.404) = 1.669, p = .218, partial η2 = .143 (Table 4). Time bin had no effect on the 
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maximum speed swam, F(2.101, 21.008) = 0.774, p = 480, partial η2 = .072. There were 
no differences in the maximum speed swam across the time bins (Table 5). There was no 
interaction between drug type and dose, F(1.740, 174.04) = 0.976, p = .417, partial η2 = 
.089. Caffeine and paraxanthine produced the same results on maximum speed 
throughout the varying doses.  
  
     
  
 
 
Table 3  
Effects of drug type on behavioral trials 
  Caffeine    Paraxanthine  
Spontaneous n M(SD) 95% CI  n M(SD) 95% CI 
Total Distance (mm) 6 365.8 (135.5) [-283.9, 298.2]  6 358.7 (289.9) [ 298.2, -283.9] 
Average Speed 
(mm/s) 
6 1.2 (0.6) [0.5, 1.9]  6 1.2 (1.0) [0.5, 1.9] 
Max Speed (mm/s) 6 13.7 (2.0) [10.7, 16.6]  6 10.4 (4.1) [7.5, 13.4] 
Evoked        
Total Distance (mm) 6 60.7 (33.7) [38.9, 84.6]  6 101.6 (43.2) [77.7, 125.4] 
Average Speed 
(mm/s) 
6 1.0 (0.6) [0.6, 1.4]  6 1.7 (0.7)  [1.3, 2.1] 
Max Speed (mm/s) 6 6.1 (1.7) [3.4, 8.9]  6 8.9 (3.9) [6.2, 11.6] 
Note. *p< .05 for F test; CI = Confidence Interval around mean differences
     
  
 
 
Table 4 
Effect of dose on behavioral trials 
  Control    Low    Med    High  
Spontaneous n M(SD) 95% CI  n M(SD) 95% CI  n M(SD) 95% CI  n M(SD) 95% CI 
Total 
Distance 
(mm) 
6 390.8 
(294.1) 
[192.7, 
588.8] 
 6 438.4 
(360.1) 
[199.9, 
676.9] 
 6 368.3  
(371.4) 
[129.8, 
606.8] 
 6 251.6 
(163.8) 
[144.9, 
358.2] 
Average 
Speed 
(mm/s) 
6 1.3 
(1.0) 
[0.6, 
2.0] 
 6 1.5 
(1.2) 
[0.7, 
2.3] 
 6 1.2 
(1.3) 
[0.4, 
2.0] 
 6 0.9 
(0.5) 
[0.5, 
1.2] 
Max Speed 
(mm/s) 
6 11.5 
(7.1) 
[6.8, 
16.3] 
 6 13.6 
(7.3) 
[9.4, 
17.8] 
 6 13.7 
(4.4) 
[10.8, 
16.7] 
 6 9.3 
(4.3) 
[6.8, 
11.8] 
Evoked                
Total 
Distance 
(mm) 
6 108.9 
(30.9) 
 
[96.6, 
121.1] 
 6 74.2 
(18.7) 
[62.0, 
86.3] 
 6 85.6 
(56.5) 
[53.6, 
117.7] 
 6 55.9 
(44.6) 
[30.9, 
80.8] 
Average 
Speed 
(mm/s) 
6 1.8 
(0.5) 
[1.6, 
2.0] 
 6 1.2 
(0.3) 
[1.0, 
1.4] 
 6 1.4 
(0.9)* 
[0.9, 
1.9] 
 6 0.9 
(0.7) 
[0.5, 
1.3] 
Max Speed 
(mm/s) 
6 7.0 
(2.9) 
[5.4, 
8.7] 
 6 8.4 
(4.1) 
[5.7, 
11.1] 
 6 8.0 
(6.5) 
[3.9, 
12.2] 
 6 6.7 
(7.7) 
[1.8, 
11.5] 
Note: *p< .05 for F test; CI = confidence interval around mean differences 
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Table 5 
Effects of time bin on behavioral trials 
  Time 
Bin 1 
   Time 
Bin 2 
   Time 
Bin 3 
   Time 
Bin 4 
 
Spontaneous n M(SD) 95% CI  n M(SD) 95% CI  n M(SD) 95% CI  n M(SD) 95% CI 
Total 
Distance 
(mm) 
6 350.6 
(192.6) 
[220.7, 
480.4] 
 6 363.6 
(242.2) 
[200.3, 
527.0] 
 6 360.3 
(185.6) 
[238.0, 
482.6] 
 6 374.5 
(276.6) 
[189.6, 
559.4] 
Average 
Speed 
(mm/s) 
6 1.2 
(0.6) 
[07.3, 
1.6] 
 6 1.2 
(0.8) 
[0.7, 
1.8] 
 6 1.2 
(0.6) 
[0.8, 
1.6] 
 6 1.2 
(0.9) 
[0.6, 
1.9] 
Max Speed 
(mm/s) 
6 11.9 
(4.6) 
[9.1, 
14.7] 
 6 11.1 
(4.2) 
[8.6, 
13.7] 
 6 12.3 
(4.2) 
[9.8, 
14.7] 
 6 12.9 
(4.1) 
[10.2, 
15.7] 
 Note: *p< .05 for F test; CI = confidence interval around mean differences
       
 
 
 
Evoked Locomotor Behavior  
 The data were analyzed using repeated measures ANOVA with dose (control, 
low, medium, high) as the within-subjects factor and drug type (caffeine, paraxanthine) 
as the between-subjects factor. Mauchly’s test indicated that the assumption of sphericity 
for dose has been met for total distance, Χ2 = 7.033, p = .221; for average speed, Χ2 = 
7.033, p = .221; and for maximum speed, Χ2 = 6.725, p = .244.   
 In contrast to spontaneous swimming, Table 3 shows drug treatments did 
influence evoked swimming in the light dimming startle assay. There was a main effect 
of drug type on swimming distance in the 20 seconds following light dimming, F(1, 10) = 
7.286, p = .022, partial η2 = .422, 95% CI of the mean differences[74.581, 7.131], with 
the Bonferroni pairwise comparison showing caffeine treated larvae swam significantly 
less than paraxanthine treated larvae (M = 60.711, SD = 33.710 and M = 101.567 SD = 
43.150 mm distance for caffeine and paraxanthine groups, respectively). Drug type also 
affected average swimming speed during startle, F(1, 10) = 7.286, p = .022, partial η2 = 
.422, 95% CI of the  mean differences [1.213, 0.119], with the Bonferroni pairwise 
comparison test showing caffeine treated larvae swimming significantly slower than 
paraxanthine treated larvae (M = 1.012 SD = 0.562 and M = 1.693, SD = 0.719 mm/s 
respectively) The maximum speed reached was not affected by drug type,  F(1, 10) = 
2.499, p = .145, partial η2 = .200.  
 There was a main effect of drug dose for total distance swam during startle 
swimming, F(3, 30) = 9.049, p < .001, partial η2 = .475. The Bonferroni pairwise 
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comparisons of dose was significant showing the control group (M = 108.9, SD = 30.9) 
swam further than the low dose group (M = 74.2, SD = 18.7) with a 95% CI[16.846, 
52.550] and the high dose group (M = 55.9, SD = 44.6) with a 95% CI[22.253, 83.788]. 
 Table 5 shows the average distance swam for each of the doses and the corresponding 
confidence intervals. There was no significant interaction between the drug dose 
administered and time bin for maximum speed, F(3.945, 39.447) = 3.044, p = .233, 
partial η2 = .233. Figure 8 shows the maximum speed across the different doses and time 
bin.    
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Figure 19. Startle swimming behaviors categorized by dose received. 
Control (no drug); Low (Caff:50𝜇M/PX:40𝜇M); Med 
(Caff:125𝜇M/PX:100𝜇M); High (Caff:250𝜇M/PX:200𝜇M). Error bars 
represent the standard error of the mean.  
 
 
Figure 20. Maximum swimming speed (mm/s) categorized by dose 
received. Control (no drug); Low (Caff:50𝜇M/PX:40𝜇M); Med 
(Caff:125𝜇M/PX:100𝜇M); High (Caff:250𝜇M/PX:200𝜇M)Figure 21. 
Startle swimming behaviors categorized by dose received. Control (no 
drug); Low (Caff:50𝜇M/PX:40𝜇M); Med (Caff:125𝜇M/PX:100𝜇M); High 
(Caff:250𝜇M/PX:200𝜇M). Error bars represent the standard error of the 
mean.  
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Figure 24. Shows the average heart rate in beats per second (bps) sorted by dose Figure 22. Maximum swimming speed (mm/s) categorized y dose 
received. Control (no drug); Low (Caff:50𝜇M/PX:40𝜇M); Med 
(Caff:125𝜇M/PX:100𝜇M); High (Caff:250𝜇M/PX:200𝜇M) 
 
Figure 23. Maximum swimming speed (mm/s) categorized by dose 
received. Control (no drug); Low (Caff:50𝜇M/PX:40𝜇M); Med 
(Caff:125𝜇M/PX:100𝜇M); High (Caff:250𝜇M/PX:200𝜇M) 
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Heart Rate Analysis 
 Hypothesis 3 suggests that heart rate will be increased by both drug type and 
dose. The data were analyzed using repeated measures ANOVA with dose (control, low, 
medium, high) as the within-subjects factor and drug type (caffeine, paraxanthine) as the 
between-subjects factor. Mauchly’s test indicated that the assumption of sphericity for 
dose has been met, Χ2 = 4.654, p = .462. Drug type had no effect on heart rate, F(1, 11) = 
0.838, p = .380, partial η2 = .071. Caffeine (n = 7) and paraxanthine (n = 6) had the same 
effects on heart rate. Figure 9 shows dose had a significant effect on heart rate (bps), F(3, 
33) = 11.187, p < .001, partial η2 = .504. The Bonferroni pairwise comparisons of heart 
rate was significant showing the control group (M = 1.75, SD = 0.442 bps) was 
significantly higher than the low dose group (M = 1.36, SD = 0.230 bps) with a 95% 
CI[0.101, 0.674] and the medium dose group (M = 1.76, SD = 0.270 bps) with a 95% 
CI[0.192, 0.956]. Figure 9 shows the control group had the highest heart rate, M = 1.750, 
SD = 0.442, the low dose group had the second highest heart rate, M = 1.364, SD = 0.230, 
followed by the highest dose group, M = 1.349, SD = 0.298, and the medium dose group 
had the lowest heart rate, M = 1.176, SD = 0.270. There was no interaction between drug 
type and dose received on heart rate, F(3, 363) = 0.060, p = .980, partial η2 = .005. 
Caffeine and paraxanthine produced the same results across all doses tested.  
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Figure 25. Shows the average heart rate in beats per second (bps) sorted 
by dose received. 
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Discussion 
These experiments were intended to provide information about effects of caffeine 
and paraxanthine on intracellular Ca2+ and behavior in an important animal model 
system, zebrafish larvae.  The lack of consistent or hypothesized caffeine and 
paraxanthine effects suggest that the dose range I used may have been too low to produce 
the intended effects in vivo within zebrafish larvae. Prior experiments investigating the 
effects of caffeine and paraxanthine used much larger doses, for example, Ladu et al. 
(2015) exposed larval zebrafish to 0.257 mM caffeine, whereas the highest concentration 
used in the current study was 250μM. Guerreiro et al., (2008) tested the neuroprotective 
qualities exposed cell cultures to 25 mM.  However, it had been suggested lower doses 
would be able to achieve the same effects while testing the effects of these drugs in vivo 
on intracellular calcium concentrations (Guerreiro et al., 2008). The doses used were 
estimates based on prior caffeine research in zebrafish models in which the zebrafish 
were expected to survive several days past drug administration (Abdelkader et al., 2013).  
 Prior research suggests exposure to caffeine or paraxanthine results in an increase 
of intracellular calcium concentrations via activation of ryanodine receptors (Guerreiro et 
al., 2008). Per hypothesis 1, I expected to see a main effect across the doses, as an 
increase in dose should result in changes in Ca2+ signaling. Contradictory to my 
hypothesis and what the literature suggested, dose did not affect the amplitude of the 
calcium oscillations. The concentrations were estimated based on prior research 
demonstrating the effects of caffeine administration in which the zebrafish also survived 
72 hours post-administration (Abdelkader et al., 2013). The last point is important 
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because I chose a dose range that would be applicable in neuroprotection studies, so I 
wanted to avoid toxic concentrations. Ryanodine receptors release Ca2+ in a bell-shaped 
dose-dependent fashion, with the receptors only activating the Ca2+ release channels in 
the intermediate range (Bezprozvanny et al., 1991; Fill & Copello, 2002; Verkhratsky, 
2006). It was expected that the dose administered would influence the frequency or 
amplitude of Ca2+ oscillations (Berridge et al., 2000, Cheng et al., 1993). However, the 
dose of caffeine or paraxanthine showed no effect on the frequency or amplitude of Ca2+ 
oscillations. It is possible the concentration of caffeine or paraxathine was either too low 
or too high to activate the Ca2+ release channels resulting in changes in intracellular Ca2+ 
concentration or affect Ca2+ oscillations.  
The literature suggests ryanodine receptors affect Ca2+ signaling by affecting the 
FM encoding of the Ca2+ signal. I broke down the ranges of frequencies measured into 
five bins (0.001 – 0.01 Hz, 0.01 – 0.05 Hz, 0.05 – 0.1 Hz, 0.1 – 1 Hz, 1-2.5 Hz) to assess 
drug effects on Ca2+ oscillations resulting at each individual frequency bin. I did not 
expect to see a main effect of drug type within the frequency bins. The results are 
congruent with the expectation there would be no main effect for drug type, per 
hypothesis 1 This is supportive to the claim that caffeine and paraxanthine have similar 
effects on Ca2+ signaling, specifically the amplitude of the frequencies. It was anticipated 
the changes in dose would impact Ca2+ oscillations, per hypothesis 1. The results did not 
coincide with the literature suggesting administration of caffeine or paraxanthine would 
result in increases of intracellular Ca2+ concentrations through activation of ryanodine 
receptors (Guerreiro et al., 2008). 
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There were several limitations affecting the analysis of spontaneous Ca2+ 
dynamics. Firstly, I created the ROIs surrounding the entire neuron cluster, rather than 
around the individual neurons forming the cluster. If the individual cells creating the 
cluster were oscillating at different times, the ROIs I used would not have been able to 
detect the changes. Using several smaller ROIs within each cluster may have allowed the 
detection of changes in the oscillations. Second, the imaging speed used (5 Hz) could 
have also prevented detection of any frequencies above 2.5 Hz. The GCaMP transgenic 
line has been recorded to respond up to at least 20 Hz (Kim & Ziff, 2014). There may 
have been effects on higher frequencies; however, the parameters used to record the 
neurons would not have been able to capture these effects, thus restricting the analysis to 
frequencies 2.5 Hz and below.  
Previous research has not explored changes in intracellular calcium 
concentrations linked to caffeine administration within the zebrafish. Paraxanthine 
administration to the zebrafish has not been documented within the literature. However, 
previous studies of intracellular calcium release channels suggest administration of 
caffeine or paraxanthine should produce an increase in intracellular calcium levels after a 
stimulus (Grienberger et al., 2012; Fill & Copello, 2013). Since ryanodine receptors 
release Ca2+ in a dose-dependent bell-shaped curve, it’s possible the doses used could 
have been either too low or too high. My results are not congruent with current literature, 
as the trails receiving different doses were similar to the control group. This suggests the 
doses administered may not have been within the correct range to produce the intended 
effects. There were no difference between caffeine and paraxanthine administration. This 
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coincides with the hypothesized outcome, however, since neither drug showed significant 
effects relative to the pre-drug control condition, it is impossible to interpret the lack of a 
main effect of drug type as evidence that the two drugs have equivalent physiological 
actions.  
 Prior research suggests caffeine exposure increases the heart rate in zebrafish 
(Abdelkader et al., 2013). The 200μM dose of caffeine did significantly affect the heart 
rate of the zebrafish. The current literature states the average resting heart rate in a 
zebrafish embryo is 2.16 bps (Burns et al., 2005). The control group, averaging at 1.75 
bps, has a lower average resting heart rate than what the literature suggest. The literature 
states embryos exposed to doses of caffeine above 100 µM significantly increases heart 
rate over control groups (Abdelkader et al, 2013). My results do not coincide with current 
literature, as the control condition in the current study had the highest heart rate, an 
opposite of caffeine from what has been previously reported . One possibility that could 
explain this is that heart rate was measured 4 times across 104 minutes in the current 
study, and the duration of restraint and exposure to the imaging laser may have led to a 
lower heart rate as part of general fatigue response to the experiment. However, none of 
the larvae died during calcium imaging and all were successfully de-embedded 
afterwards.  
The differences in spontaneous swimming behaviors attributed to change in dose 
of the zebrafish post treatment were not consistent with previous reports (Holtzman, 
1989; Ladu et al., 2015). Acute caffeine exposure was shown to decrease active voluntary 
behaviors, including spontaneous swimming behaviors, in a dose dependent fashion, in 
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two separate studies (Holtzman, 1989; Ladu et al., 2015). However, I saw no significant 
differences between the total distance traveled, average speed, or the minimum speed 
during the 20 minute time bin across the four doses tested in this experiment. Doses of 
caffeine under 100 µM do not produce changes in swimming behaviors (Abdelkader et 
al., 2013; Capiotti et al., 2011). Since paraxanthine is the main metabolite of caffeine, I 
assumed that there would be no changes in swimming behavior after exposure to 80 µM 
of paraxanthine. As the low dose conditions for caffeine and paraxanthine was less than 
the aforementioned concentrations, my results for the low dose condition are congruent 
with previous research as the low dose group was not significantly different from the 
control group.  
I broke up the 20 minute time bin into four sets of 5 minute time bins to more 
closely examine the effects possibility that drug effects change over time within each 20 
minute behavior recording. There were no significant differences in voluntary swimming 
behaviors across the time bins. However, there was a significant interaction between the 
dose and time bin. This interaction suggests the varying doses may influence the speed 
the zebrafish metabolizes caffeine and paraxanthine.  
By using a metabolically equivalent ratio of paraxanthine to caffeine, I did not 
expect to see any main effects of drug type in the analysis. My results were consistent 
with our hypothesis as there were no discernible differences between the groups treated 
with caffeine or paraxanthine. To some extent these results support the suggestion that 
caffeine and paraxanthine affect the same receptors to produce similar behaviors. 
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However, as mentioned previously, the lack of significant different across drug dosages 
limits any interpretations of these results.  
One clear limiation to my experimental design was that time and drug dosage 
were confounded, since drugs were given as progressively higher concentrations over 
time and measurements were made repeatedly.  I was unable to counterbalance the doses 
administered during this experiment. It would have been difficult to ensure that the higher 
doses would have been fully flushed from the zebrafish’s system before testing the lower 
doses. This makes it possible that other processes related to the passage of time or 
experimental procedures, including simple fatigue, may have influenced cellular or 
behavioral responses to the drugs. It is also possible that prolonged exposure to affected 
results, for example, if previous exposure to lower doses bunted the responses to higher 
doses through a type of tolerance or habituation mechanism. 
Future research is needed to provide further understanding of the effects caffeine 
and paraxanthine on Ca2+ signaling. The next step would be to test a wider range of 
doses, which will provide information on the ideal dose to activate ryanodine receptors in 
order to affect intracellular Ca2+ concentrations. Increasing the imaging speed would 
allow researchers to analyze a broader range of frequencies to identify changes in Ca2+ 
oscillations this experiment was unable to assess due to the parameters of the Ca2+ 
imaging. To avoid confounds related to time and previous drug exposure, any follow up 
experiment should probably use a between subjects design in which animals receive only 
one exposure to the drug.  
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The neuroprotective effects of caffeine are supported by a numerous studies 
investigating the effects in humans, animal models, and in cell. Calcium, the most 
prominent signaling molecule within cells, is known to have a role in inducing apoptosis. 
Several studies have linked PD-related DA death to complications with calcium. The 
neuroprotective qualities of caffeine are attributed to its main metabolite paraxanthine 
which causes the release of calcium from the ER via ryanodine receptors.  Although this 
study did not provide evidence caffeine’s or paraxanthine’s effect on intracellular 
calcium signaling, the literature still supports caffeine as a strong candidate for a potential 
therapeutic treatment in neurodegenerative diseases.  
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Appendix A: Confocal Trigger for Dark Flash Calcium Imaging 
light = 1 
confocal = 0 
 
while (1) 
if (confocal == 1) 
 light = 0 
 delay (var.delay) 
 light = 1 
 endif 
endwhile 
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Appendix B: Spontaneous and Dimming Startle Script 
while (1) 
while (var.capture == 1) 
//pixelink1 = 5 
pixelink1 = 5 
delay (.2) 
//pixelink1 = 0 
Pixelink1 = 0  
var.pics = var.pics +1 
delay (.79) // .5Hz frame rate 
endwhile 
endwhile 
 
//equal recording time before and after stim 
var.capture = 0 
var.taps = 0 
var.trials = 0 
 
delay (120) 
 
while (var.numdims > var.dims) 
 
//DIM 
var.trials = var.trials +1 
 toplight = 1 
 var.capture = 1 
 delay (car.prestim*60) 
 lightled = 1 
highspeed = 1 
toplight = 0 
delay (var.lightoff*60) 
var.capture = 0 
highspeed = 0 
lightled = 0 
 
var.dims = var.dims +1 //count up another trial 
 
end while 
 
endseq(cameras) 
toplight = 1 
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Appendix C: Spectral Analysis Script for Analyzing Calcium Oscillations 
 
Treatment ={‘PX’};%%These first two lines are for uploading 
data from folders, probably not necessary 
date={'6-21'};%% 
close all 
bin1 = [ .001 .01 .05 .1 1];%%setting the lower bounds for 
the bins 
bin2 = [ .01 .05 .1 1 2.5];%%setting the upper bounds for 
the bins 
color=('bgrk');%%colors for graphing different data sets 
Exp_cond = ([Control, low_dose, med_dose, 
high_dose]);%%list of data sets to be analyzed 
for j=1%:4 
x = Exp_cond(:,j); 
dt=.2; 
T=1200; 
 
xf = fft(x); 
Sxx = 2*dt^2/T * xf.*conj(xf); %2. Compute the power 
spectrum. 
Sxx = Sxx(1:length(x)/2+1); %3. Ignore negative 
frequencies. 
df = 1/max(T); %4. Determine the frequency resolution. 
fNQ = 1/dt/2; %5. Calculate the Nyquist Frequency 
faxis = (0:df:fNQ); %6. Construct the frequency axis. 
 
C=sort(abs(Sxx),'descend'); % Finding dominant frequencies 
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norm=C(2); % Choosing largest frequency to normalize data 
 
for i=1:length(bin1) 
J=intersect(find(faxis>=bin1(i)),find(faxis<=bin2(i)))
;%Determining indices in faxis corresponding to 
frequencies in bin i 
a=min(J);% index (in faxis) of lowest frequency in bin 
i 
b=max(J);%index (in faxis) of highest frequency in bin 
i 
A(a:b)=Sxx(a:b);%determining power of frequencies in 
bin i 
  
  B = (Sxx(a:b)/norm); %normalizing bin i 
  mean1(j,i+1)=real(mean(B));%calculating mean of bin i 
  std1(j,i+1)=real(std(B));%calculating std of bin i 
  clear A 
  clear B 
  clear J 
  
end  % end for i 
end % end for j 
 
%%graph 
errorbar(mean1(1,:),std1(1,:),color(1),'LineStyle','none') 
hold on 
plot((2:1:length(bin1)+1), mean1(1,2:6),[color(1) 
'*'],'MarkerFaceColor',color(1)) 
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errorbar(mean1(2,:),std1(2,:),color(2),'LineStyle','none') 
plot((2:1:length(bin1)+1), mean1(2,2:6),[color(2) 
'*'],'MarkerFaceColor',color(2)) 
errorbar(mean1(3,:),std1(3,:),color(3),'LineStyle','none') 
plot((2:1:length(bin1)+1), mean1(3,2:6),[color(3) 
'*'],'MarkerFaceColor',color(3)) 
errorbar(mean1(4,:),std1(4,:),color(4),'LineStyle','none') 
plot((2:1:length(bin1)+1), mean1(4,2:6),[color(4) 
'*'],'MarkerFaceColor',color(4)) 
xtick=[1 2 3 4 5 6 7 8]; 
myxticklabel={'','(0.001-0.01)','(0.01-0.05)','(0.05-
0.1)','(.1-1)','(1-2.5)','', ''} 
set(gca,'XTick',xtick,'XTickLabels',myxticklabel,'Fontsize'
,12) 
xlabel('Frequency ranges (Hz)','FontSize',14) 
ylabel('Normalized power', 'FontSize',14) 
legend('','Control','','40um','','100um','','200um') 
title(['Normalized power of different frequencies, ' 
date{1} ' (' treatment{1} ')'],'FontSize',14) 
